Section Arrow
Quote
XTNT.NYSE-M
- Xtant Medical Holdings
Quotes are at least 15-min delayed:2025/06/28 13:12 EDT
Last
 0.629
+0.0132 (+2.14%)
Day High 
0.64 
Prev. Close
0.6158 
1-M High
0.749 
Volume 
43.23K 
Bid
0.56
Ask
0.69
Day Low
0.6032 
Open
0.64 
1-M Low
0.5715 
Market Cap 
85.80M 
Currency USD 
P/E 72.01 
%Yield -- 
10-SMA 0.62 
20-SMA 0.65 
50-SMA 0.59 
52-W High 0.8325 
52-W Low 0.331 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.09/-0.30
Enterprise Value
108.05M
Balance Sheet
Book Value Per Share
0.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
117.27M
Operating Revenue Per Share
0.49
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/28 13:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products includeOsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.